Drug Recalls - December - 2010 - Labeling

Drug Articles

Home

Latest Drug News

News Blog

December 2010 Labeling Changes

Friday, 14 January 2011 16:52 |

As of December 2010, the FDA has changed the labels of 58 products.

The following drugs had modifications to the BOXED WARNINGS, CONTRAINDICATIONS and WARNINGS sections:

Ablavar (gadofosveset trisodium)

Aceon (perindopril erbumine)

Baraclude (entecavir)

Copegus (ribavirin)

Eovist (Gadoxetate disodium) injection

Innopran XL (propranolol hydrochloride)

Magnevist (gadopentetate dimeglumine)

MultiHance (gadobenate dimeglumine)

Omniscan (gadodiamide)

Optimark (gadoversetamide)

Prilosec OTC (omeprazole magnesium)

Pristiq (desvenlafaxine)

Prohance (gadoteridol)

Relenza (zanamivir)

Remicade (inflximab)

Terconazole Vaginal Cream

Zegerid OTC capsules

Zerit (stavudine)

Have You Been Injured?

Free Claim Review
If you or a loved one have suffered a serious injury or side effect related to drug or supplement, please contact us for a free and confidential case review.

Name:

Email:

Address:

City:

State:

Zip Code:

Day Phone:

Evening Phone:

Have you been injured or experienced side-effects due to a drug or supplement?:

Yes
No

Name of Drug(s) or Supplement(s):

Date(s) of Drug / Supplement Use:

Date(s) of Injury or Diagnosis Related to Drug / Supplement Use:

Please describe problem or injury:

Enter the code you see in the box:

Polls

Do You Think The FDA Is Doing Enough To Protect Consumers?

	Yes
	No
	Don't Know

Drug Recalls, Copyright © 2001 - 2011. All Rights Reserved.
DrugRecalls.com - Drug Recalls provides information about U.S. Food and Drug Administration drug recall, warning, and safety issues involving prescription drugs, over-the-counter drugs, dietary supplements. Drug Recalls is a legal newsletter. Our attorneys provide legal advice on drug recalls, drug alerts, drug warnings, and practice law in federal courts across the United States and in jurisdictions or states where licensed to practice.
Sponsored by attorney Dana Taschner. 1-800-448-5800
Please Read our Terms Of Use